Logo image of ACB.CA

AURORA CANNABIS INC (ACB.CA) Stock Price, Forecast & Analysis

Canada - Toronto Stock Exchange - TSX:ACB - CA05156X8504 - Common Stock

6.27 CAD
-0.1 (-1.57%)
Last: 12/24/2025, 7:00:00 PM

ACB.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap352.50M
Revenue(TTM)367.13M
Net Income(TTM)-58.89M
Shares56.22M
Float56.19M
52 Week High9.9
52 Week Low4.95
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.36
PEN/A
Fwd PE16.12
Earnings (Next)02-03 2026-02-03/bmo
IPO2007-09-26
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


ACB.CA short term performance overview.The bars show the price performance of ACB.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10 -15

ACB.CA long term performance overview.The bars show the price performance of ACB.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -10 -20 -30 -40

The current stock price of ACB.CA is 6.27 CAD. In the past month the price decreased by -2.49%. In the past year, price increased by 0.97%.

AURORA CANNABIS INC / ACB Daily stock chart

ACB.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
BHC.CA BAUSCH HEALTH COS INC 1.88 3.65B
TLRY.CA TILRAY BRANDS INC N/A 1.61B
CRON.CA CRONOS GROUP INC 25.07 1.44B
DHT-UN.CA DRI HEALTHCARE TRUST 7.11 881.76M
WEED.CA CANOPY GROWTH CORP N/A 655.86M
GUD.CA KNIGHT THERAPEUTICS INC N/A 592.76M
NGEN.CA NERVGEN PHARMA CORP N/A 528.16M
TSND.CA TERRASCEND CORP N/A 405.08M
CPH.CA CIPHER PHARMACEUTICALS INC 16.78 383.09M
HITI.CA HIGH TIDE INC N/A 339.40M
OGI.CA ORGANIGRAM GLOBAL INC N/A 323.74M
XLY.CA AUXLY CANNABIS GROUP INC 3.62 195.52M

About ACB.CA

Company Profile

ACB logo image Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Company Info

AURORA CANNABIS INC

2207 90B Street Sw

Leduc ALBERTA T9E 0V6 CA

CEO: Miguel Martin

Employees: 1073

ACB Company Website

ACB Investor Relations

Phone: 16043625207

AURORA CANNABIS INC / ACB.CA FAQ

Can you describe the business of AURORA CANNABIS INC?

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


Can you provide the latest stock price for AURORA CANNABIS INC?

The current stock price of ACB.CA is 6.27 CAD. The price decreased by -1.57% in the last trading session.


Does ACB stock pay dividends?

ACB.CA does not pay a dividend.


How is the ChartMill rating for AURORA CANNABIS INC?

ACB.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the expected growth for ACB stock?

The Revenue of AURORA CANNABIS INC (ACB.CA) is expected to grow by 11.1% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the market capitalization of ACB stock?

AURORA CANNABIS INC (ACB.CA) has a market capitalization of 352.50M CAD. This makes ACB.CA a Small Cap stock.


What is the ownership structure of AURORA CANNABIS INC (ACB.CA)?

You can find the ownership structure of AURORA CANNABIS INC (ACB.CA) on the Ownership tab.


ACB.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ACB.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ACB.CA. The financial health of ACB.CA is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ACB.CA Financial Highlights

Over the last trailing twelve months ACB.CA reported a non-GAAP Earnings per Share(EPS) of -0.36. The EPS increased by 57.85% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -7.78%
ROE -11.07%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%-4.55%
Sales Q2Q%11.4%
EPS 1Y (TTM)57.85%
Revenue 1Y (TTM)23.87%

ACB.CA Forecast & Estimates

9 analysts have analysed ACB.CA and the average price target is 8.08 CAD. This implies a price increase of 28.92% is expected in the next year compared to the current price of 6.27.

For the next year, analysts expect an EPS growth of -1574.6% and a revenue growth 11.1% for ACB.CA


Analysts
Analysts73.33
Price Target8.08 (28.87%)
EPS Next Y-1574.6%
Revenue Next Year11.1%

ACB.CA Ownership

Ownership
Inst Owners21.18%
Ins Owners0.04%
Short Float %N/A
Short RatioN/A